Subsense, a brain-computer interface startup, has raised $27 million in seed funding to develop nanoparticle-based non-invasive BCI technology, aiming to revolutionize neurological disease treatment and challenge existing invasive solutions.
Techub News reports that brain-computer interface startup Subsense has raised $27 million in seed funding to develop nanoparticle-based non-invasive BCI technology. The company aims to revolutionize neurological disease treatment and challenge existing invasive solutions. (Source: Crypto Briefing)
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
